Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amarin Development AB

Division of Allergan PLC
www.amarindev.com

Latest From Amarin Development AB

Device Firms Should Not Ignore Pharma Off-Label Suits, Experts Say

While recent case law that appears to give industry more leverage in off-label communications involves drugs, the precedent should apply equally to devices, attorneys say. Nonetheless, companies should be cautious about moving full-steam ahead with off-label promotions

Medical Device Advertising, Marketing & Sales

Recent Dealmaking (12/2003)

Summarizing the month in European dealmaking.

Recent Dealmaking (7/2003)

Summarizing the month in European dealmaking.
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Site Specific
  • Therapeutic Areas
  • Gastrointestinal
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Sweden
  • Parent & Subsidiaries
  • Allergan PLC
  • Senior Management
  • Peter Fyhr, Dir., R&D
    Carina Agardsson, Head, Fin. & Admin.
  • Contact Info
  • Amarin Development AB
    Phone: (46) 0405 39800
    Lundavägen 151
    Malmö, SE-212 24
    Sweden
Advertisement
Advertisement
UsernamePublicRestriction

Register